Published in Gut on October 01, 1999
Outcomes in children after intestinal transplant. Pediatrics (2010) 0.95
Long-term outcome of congenital intestinal pseudoobstruction. Dig Dis Sci (2002) 0.95
Acute on chronic intestinal pseudo-obstruction as a cause of death in a previously healthy twenty-year-old male. Dig Dis Sci (2006) 0.87
Nationwide survey on adult type chronic intestinal pseudo-obstruction in surgical institutions in Japan. Surg Today (2012) 0.85
A meta-analysis of clinical outcome in patients with total intestinal aganglionosis. Pediatr Surg Int (2009) 0.77
Small bowel review: Normal physiology, part 2. Dig Dis Sci (2003) 0.75
Primary intestinal autoimmune disease as a cause of chronic intestinal pseudo-obstruction. Gut (2005) 0.75
Pseudo-obstruction in children: transplant or wait? Gut (1999) 0.75
Pre-emptive Intestinal Transplant: The Surgeon's Point of View. Dig Dis Sci (2017) 0.75
A meta-analysis of clinical outcome of intestinal transplantation in patients with total intestinal aganglionosis. Pediatr Surg Int (2017) 0.75
Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg (1998) 2.31
Diagnosis and treatment of chronic intestinal pseudo-obstruction in children: report of consensus workshop. J Pediatr Gastroenterol Nutr (1997) 1.79
Predicting the clinical response to cisapride in children with chronic intestinal pseudo-obstruction. Am J Gastroenterol (1993) 1.62
Chronic intestinal pseudo-obstruction syndrome in pediatrics. Results of a national survey by members of the North American Society of Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr (1988) 1.56
Rectal epithelial cell proliferation patterns as predictors of adenomatous colorectal polyp recurrence. Gut (1993) 1.39
Current status of intestinal transplantation in children. J Pediatr Surg (1998) 1.28
230 patient years of experience with home long-term parenteral nutrition in childhood: natural history and life of central venous catheters. J Pediatr Surg (1994) 1.27
Factors impacting the survival of children with intestinal failure referred for intestinal transplantation. J Pediatr Surg (1999) 1.14
Endoscopies in pediatric small intestinal transplant recipients: five years experience. Am J Gastroenterol (1998) 1.02
Anatomic variability of rejection in intestinal allografts after pediatric intestinal transplantation. J Pediatr Gastroenterol Nutr (1998) 0.92
Immune deficiencies in chronic intestinal pseudo-obstruction. Acta Paediatr (1997) 0.90
Small intestinal transplantation for irreversible intestinal failure in children. Dig Dis Sci (1997) 0.87
Antroduodenojejunal manometry in the diagnosis of chronic idiopathic intestinal pseudoobstruction in children. J Pediatr Gastroenterol Nutr (1994) 0.86
Intestinal motility and jejunal feeding in children with chronic intestinal pseudo-obstruction. Gastroenterology (1995) 0.85
Manometrical evaluation in visceral neuropathies in children. J Pediatr Gastroenterol Nutr (1994) 0.84
"Munchausen by proxy" syndrome in a small bowel transplant recipient. Transplant Proc (1996) 0.83
Overinterpretation of gastroduodenal motility studies: two cases involving Munchausen syndrome by proxy. J Pediatr (1995) 0.82
Gastrointestinal motility in neonatal and pediatric practice. Gastroenterol Clin North Am (1996) 0.81
Intestinal transplantation in composite visceral grafts or alone. Ann Surg (1992) 4.96
A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet (1998) 3.33
Outcome analysis of 71 clinical intestinal transplantations. Ann Surg (1995) 2.95
Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg (2000) 2.91
Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation (1992) 2.75
The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med (1995) 2.68
Management of intestinal transplantation in humans. Transplant Proc (1992) 2.62
Epidemiology of childhood constipation: a systematic review. Am J Gastroenterol (2006) 2.33
A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Pediatr (1979) 2.32
Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg (1998) 2.31
Three years clinical experience with intestinal transplantation. J Am Coll Surg (1994) 2.20
The spectrum of pediatric eosinophilic esophagitis beyond infancy: a clinical series of 30 children. Am J Gastroenterol (2000) 2.10
Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. J Clin Microbiol (1997) 2.05
Pathology of human intestinal transplantation. Gastroenterology (1996) 1.98
Logistics and technique for combined hepatic-intestinal retrieval. Ann Surg (1992) 1.85
Diagnosis and treatment of chronic intestinal pseudo-obstruction in children: report of consensus workshop. J Pediatr Gastroenterol Nutr (1997) 1.79
Monitoring and treatment of intestinal allograft rejection in humans. Transplant Proc (1993) 1.78
Effect of the anesthetics benzyl alcohol and chloroform on bilayers made from monolayers. Biophys J (1979) 1.78
Use of FK 506 in pediatric patients. Transplant Proc (1991) 1.77
Small intestinal transplantation in humans with or without the colon. Transplantation (1994) 1.74
Fifty years of experience with propylthiouracil-associated hepatotoxicity: what have we learned? J Clin Endocrinol Metab (1997) 1.68
Predicting the clinical response to cisapride in children with chronic intestinal pseudo-obstruction. Am J Gastroenterol (1993) 1.62
Nonadherence consensus conference summary report. Am J Transplant (2009) 1.61
Liver transplantation for polycystic liver disease. Arch Surg (1990) 1.61
Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation. Transplantation (1995) 1.59
Weaning of immunosuppression in long-term liver transplant recipients. Transplantation (1995) 1.59
Constipation in infants and children: evaluation and treatment. A medical position statement of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr (1999) 1.57
Weaning of immunosuppression in liver transplant recipients. Transplantation (1997) 1.57
Piggyback orthotopic intestinal transplantation. Surg Gynecol Obstet (1993) 1.55
Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both. Transplantation (2000) 1.53
Gastrointestinal presentation of Langerhans cell histiocytosis in a child with perianal skin tags: a case report. J Pediatr Gastroenterol Nutr (2004) 1.50
Reducing pediatric liver transplant complications: a potential roadmap for transplant quality improvement initiatives within North America. Am J Transplant (2012) 1.46
Lack of useful clinical predictors of response to splenectomy in patients with chronic idiopathic thrombocytopenic purpura. Br J Haematol (1990) 1.45
Early-onset progressive ataxia associated with the first CACNA1A mutation identified within the I-II loop. J Neurol Sci (2007) 1.44
Clinical intestinal transplantation: a decade of experience at a single center. Ann Surg (2001) 1.44
Esophageal motor abnormalities in children with gastroesophageal reflux and peptic esophagitis. J Pediatr (1986) 1.43
Intestinal transplantation at the University of Pittsburgh. Transplant Proc (1994) 1.42
Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): evidence for heterogeneity. Hepatology (1997) 1.41
Post-transplant lymphoproliferative disorders in children: the role of chemotherapy in the era of rituximab. Pediatr Transplant (2009) 1.40
Abdominal multivisceral transplantation. Transplantation (1995) 1.37
Drug-induced agranulocytosis: prognostic factors in a series of 168 episodes. Br J Haematol (1991) 1.35
Serial measurement of Epstein-Barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disease. Transplantation (1998) 1.33
Indications for pediatric intestinal transplantation: a position paper of the American Society of Transplantation. Pediatr Transplant (2001) 1.32
Xanthogranulomatous cholecystitis: clinical, sonographic, and CT findings in 26 patients. AJR Am J Roentgenol (2000) 1.31
Localized CT-guided irradiation inhibits neurogenesis in specific regions of the adult mouse brain. Radiat Res (2011) 1.30
Current status of intestinal transplantation in children. J Pediatr Surg (1998) 1.28
Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation (1998) 1.28
Clinical small bowel or small bowel plus liver transplantation under FK 506. Transplant Proc (1991) 1.24
Epstein-Barr virus load monitoring: its role in the prevention and management of post-transplant lymphoproliferative disease. Transpl Infect Dis (2001) 1.22
MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells. Clin Exp Metastasis (1997) 1.19
Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years. Transplantation (2003) 1.18
Adult outcomes of pediatric recurrent abdominal pain: do they just grow out of it? Pediatrics (2001) 1.18
Temporary end to side portacaval shunt in orthotopic hepatic transplantation in humans. Surg Gynecol Obstet (1993) 1.18
Rumination syndrome in adolescents. J Pediatr (2000) 1.17
Intestinal and pulmonary cryptosporidiosis in an infant with severe combined immune deficiency. J Pediatr Gastroenterol Nutr (1984) 1.14
Factors impacting the survival of children with intestinal failure referred for intestinal transplantation. J Pediatr Surg (1999) 1.14
Clinical intestinal transplantation: focus on complications. Transplant Proc (1992) 1.11
Prevalence, pattern and predictors of use of complementary and alternative medicine (CAM) in migraine patients attending a headache clinic in Italy. Cephalalgia (2005) 1.11
Epstein-Barr virus gene expression in the peripheral blood of transplant recipients with persistent circulating virus loads. J Infect Dis (2000) 1.11
Allospecific CD154+ T cells associate with rejection risk after pediatric liver transplantation. Am J Transplant (2008) 1.10
Mutations of bacteriophage lambda that define independent but overlapping RNA processing and transcription termination sites. J Mol Biol (1986) 1.09
Graft-versus-host disease after liver and small bowel transplantation in a child. Clin Transplant (1997) 1.09
Cryptococcal meningitis after liver transplantation. Transplantation (1996) 1.08
Identification of a locus for progressive familial intrahepatic cholestasis PFIC2 on chromosome 2q24. Am J Hum Genet (1997) 1.08
Cisapride for gastro-oesophageal reflux and peptic oesophagitis. Arch Dis Child (1987) 1.08
Augmentation of chimerism with perioperative donor bone marrow infusion in organ transplant recipients: a 44 month follow-up. Transplant Proc (1997) 1.07
The nature of the voltage-dependent conductance of the hemocyanin channel. J Membr Biol (1975) 1.05
Two groups of chronic myelomonocytic leukaemia: myelodysplastic and myeloproliferative. Prognostic implications in a series of a single center. Leuk Res (2002) 1.05
Induction and general properties of beta-galactosidase and beta-galactoside permease in Pseudomonas BAL-31. J Bacteriol (1977) 1.05
Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in childhood and adolescence. J Pediatr (2000) 1.04
Bacterial translocation in clinical intestinal transplantation. Transplantation (2001) 1.03
Gastric emptying with gastro-oesophageal reflux. Arch Dis Child (1987) 1.03
Percutaneous transluminal angioplasty of venous anastomotic stenoses complicating liver transplantation: intermediate-term results. J Vasc Interv Radiol (1994) 1.03
Hepatic hemangioendothelioma: clinical experience and management strategy. J Pediatr Surg (1999) 1.03
Changes in interfacial potentials induced by carbonylcyanide phenylhydrazone uncouplers: possible role in inhibition of mitochondrial oxygen consumption and other transport processes. Membr Biochem (1984) 1.03
Internal hernia and volvulus of the small bowel following liver transplantation. Transpl Int (1997) 1.02
Liver resection combined with excision of vena cava. J Am Coll Surg (2000) 1.02
Endoscopies in pediatric small intestinal transplant recipients: five years experience. Am J Gastroenterol (1998) 1.02
Intestinal transplantation in children under FK 506 immunosuppression. J Pediatr Surg (1993) 1.02
What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients. Ann Surg (1999) 1.02
The phylogeography of dusky dolphins (Lagenorhynchus obscurus): a critical examination of network methods and rooting procedures. Mol Ecol (2003) 1.01
FK 506-associated diabetes mellitus in the pediatric transplant population is a rare complication. Transplant Proc (1991) 1.01
Apoptotic chondrocytes from osteoarthrotic human articular cartilage and abnormal calcification of subchondral bone. J Rheumatol (2000) 1.01
Postviral gastroparesis: presentation, treatment, and outcome. J Pediatr (1997) 1.01
Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia (2006) 1.00
Split-liver transplantation: a comparison of ex vivo and in situ techniques. J Pediatr Surg (2000) 1.00
Concomitant infusion of unmodified donor bone marrow into unconditioned recipients of intestinal allografts. Transplant Proc (1996) 1.00
Epstein Barr virus associated posttransplant lymphoproliferative disease after intestinal transplantation. Transplant Proc (1996) 0.99
Rejection of human intestinal allografts: alone or in combination with the liver. Transplant Proc (1994) 0.99